Literature DB >> 17984457

A 54-year-old man with slowness of movement and confusion.

Michael D Geschwind, Keith A Josephs, Joseph E Parisi, B Mark Keegan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17984457      PMCID： PMC2637148          DOI： 10.1212/01.wnl.0000290370.14036.69

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  21 in total

1.  Diffusion-weighted MR findings in isolated angiitis of the central nervous system (IACNS).

Authors:  S-Y Lee; K Chu; K-I Park; S-W Jeong; B-W Yoon
Journal:  Acta Neurol Scand       Date:  2003-11       Impact factor: 3.209

Review 2.  Pancreatic encephalopathy. A case report and review of the literature.

Authors:  P Boon; J de Reuck; E Achten; J de Bleecker
Journal:  Clin Neurol Neurosurg       Date:  1991       Impact factor: 1.876

3.  Metal-induced diseases of the nervous system.

Authors:  P M Le Quesne
Journal:  Br J Hosp Med       Date:  1982-11

4.  A simple and effective method for inactivating virus infectivity in formalin-fixed tissue samples from patients with Creutzfeldt-Jakob disease.

Authors:  P Brown; A Wolff; D C Gajdusek
Journal:  Neurology       Date:  1990-06       Impact factor: 9.910

Review 5.  Pancreatic encephalopathy: a 7-year follow-up case report and review of the literature.

Authors:  R M Ruggieri; I Lupo; F Piccoli
Journal:  Neurol Sci       Date:  2002-10       Impact factor: 3.307

6.  CNS vasculitis and vasculopathy: efficacy and usefulness of diffusion-weighted echoplanar MR imaging.

Authors:  Toshio Moritani; Akio Hiwatashi; David A Shrier; Henry Z Wang; Yuji Numaguchi; Per-Lennart A Westesson
Journal:  Clin Imaging       Date:  2004 Jul-Aug       Impact factor: 1.605

Review 7.  Autoimmune encephalopathies.

Authors:  Steven Vernino; Michael Geschwind; Bradley Boeve
Journal:  Neurologist       Date:  2007-05       Impact factor: 1.398

Review 8.  Frontal-subcortical circuits and human behavior.

Authors:  J L Cummings
Journal:  Arch Neurol       Date:  1993-08

9.  Challenging the clinical utility of the 14-3-3 protein for the diagnosis of sporadic Creutzfeldt-Jakob disease.

Authors:  Michael D Geschwind; Jennifer Martindale; Deborah Miller; Stephen J DeArmond; Jane Uyehara-Lock; David Gaskin; Joel H Kramer; Nicholas M Barbaro; Bruce L Miller
Journal:  Arch Neurol       Date:  2003-06

Review 10.  Diffusion-weighted MRI abnormalities as an early diagnostic marker for Creutzfeldt-Jakob disease.

Authors:  Y Shiga; K Miyazawa; S Sato; R Fukushima; S Shibuya; Y Sato; H Konno; K Doh-ura; S Mugikura; H Tamura; S Higano; S Takahashi; Y Itoyama
Journal:  Neurology       Date:  2004-08-10       Impact factor: 9.910
View more
  15 in total

1.  Whipple's disease masquerades as dementia with Lewy bodies.

Authors:  Kyle Hurth; Rawan Tarawneh; Nupur Ghoshal; Tammie L S Benzinger; David B Clifford; Michael Geschwind; John C Morris; James E Galvin; Robert E Schmidt; Nigel J Cairns
Journal:  Alzheimer Dis Assoc Disord       Date:  2015 Jan-Mar       Impact factor: 2.703

2.  Differential diagnosis of Jakob-Creutzfeldt disease.

Authors:  Ross W Paterson; Charles C Torres-Chae; Amy L Kuo; Tim Ando; Elizabeth A Nguyen; Katherine Wong; Stephen J DeArmond; Aissa Haman; Paul Garcia; David Y Johnson; Bruce L Miller; Michael D Geschwind
Journal:  Arch Neurol       Date:  2012-12

3.  Glucose metabolism in sporadic Creutzfeldt-Jakob disease: a statistical parametric mapping analysis of (18) F-FDG PET.

Authors:  E-J Kim; S-S Cho; B-H Jeong; Y-S Kim; S W Seo; D L Na; M D Geschwind; Y Jeong
Journal:  Eur J Neurol       Date:  2011-11-04       Impact factor: 6.089

4.  Clinical overlap between Jakob-Creutzfeldt disease and Lewy body disease.

Authors:  Maria Carmela Tartaglia; David Y Johnson; Julie Ngoc Thai; Tatiana Cattaruzza; Katherine Wong; Paul Garcia; Stephen J Dearmond; Bruce L Miller; Michael D Geschwind
Journal:  Can J Neurol Sci       Date:  2012-05       Impact factor: 2.104

5.  Pathologic evidence that the T188R mutation in PRNP is associated with prion disease.

Authors:  Maria Carmela Tartaglia; Julie N Thai; Tricia See; Amy Kuo; Robert Harbaugh; Benjamin Raudabaugh; Ignazio Cali; Mamta Sattavat; Henry Sanchez; Stephen J DeArmond; Michael D Geschwind
Journal:  J Neuropathol Exp Neurol       Date:  2010-12       Impact factor: 3.685

6.  Familial Creutzfeldt-Jakob disease with V180I mutation.

Authors:  Tae-Il Yang; Dae-Soo Jung; Bo-Young Ahn; Byung-Hoon Jeong; Han-Jeong Cho; Yong-Sun Kim; Duk L Na; Michael D Geschwind; Eun-Joo Kim
Journal:  J Korean Med Sci       Date:  2010-06-16       Impact factor: 2.153

7.  Sporadic Jakob-Creutzfeldt disease presenting as primary progressive aphasia.

Authors:  David Y Johnson; Diana L Dunkelberger; Maya Henry; Aissatou Haman; Michael D Greicius; Katherine Wong; Stephen J DeArmond; Bruce L Miller; Maria Luisa Gorno-Tempini; Michael D Geschwind
Journal:  JAMA Neurol       Date:  2013-02       Impact factor: 18.302

Review 8.  Prion Diseases.

Authors:  Michael D Geschwind
Journal:  Continuum (Minneap Minn)       Date:  2015-12

9.  Genetic Prion Disease Caused by PRNP Q160X Mutation Presenting with an Orbitofrontal Syndrome, Cyclic Diarrhea, and Peripheral Neuropathy.

Authors:  Jamie C Fong; Julio C Rojas; Jee Bang; Andrea Legati; Katherine P Rankin; Sven Forner; Zachary A Miller; Anna M Karydas; Giovanni Coppola; Carrie K Grouse; Jeffrey Ralph; Bruce L Miller; Michael D Geschwind
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

10.  Shortening heparan sulfate chains prolongs survival and reduces parenchymal plaques in prion disease caused by mobile, ADAM10-cleaved prions.

Authors:  Patricia Aguilar-Calvo; Alejandro M Sevillano; Jaidev Bapat; Katrin Soldau; Daniel R Sandoval; Hermann C Altmeppen; Luise Linsenmeier; Donald P Pizzo; Michael D Geschwind; Henry Sanchez; Brian S Appleby; Mark L Cohen; Jiri G Safar; Steven D Edland; Markus Glatzel; K Peter R Nilsson; Jeffrey D Esko; Christina J Sigurdson
Journal:  Acta Neuropathol       Date:  2019-10-31       Impact factor: 17.088
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.